Startups
Vivacelle Bio is a biotechnology company advancing new paradigms in the survival of massive blood loss and severe infection.
Overview
Location
United States, Louisiana, Shreveport
Phone
+1 318-771-1294
Total raised
$5.3M
Founded date
2013
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 24, 2020 | Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens |
Reviews 0
FAQ about Vivacelle Bio, Incorporated
When was Vivacelle Bio, Incorporated founded?
Vivacelle Bio, Incorporated was founded in 2013.
How much funding has Vivacelle Bio, Incorporated raised?
Vivacelle Bio, Incorporated has raised $5.3M in total across 1 funding round.
What has the press written about Vivacelle Bio, Incorporated?
Parsers VC has collected 2 articles mentioning Vivacelle Bio, Incorporated, among them “Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other P...” (Nov 24, 2020).
Is Vivacelle Bio, Incorporated still active?
Yes, Vivacelle Bio, Incorporated is active; its latest activity on Parsers VC dates from Feb 10, 2023.